Advances on the structure of the R2TP/Prefoldin-like complex by Muñoz-Hernández, Hugo et al.
 1 
 
Advances on the structure of the R2TP/Prefoldin-like 
complex 
 
Hugo Muñoz-Hernández1§, Mohinder Pal2§, Carlos F. Rodríguez1,§, Chrisostomos 
Prodromou2, Laurence H. Pearl2 and Oscar Llorca1* 
 
 
1) Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 
28029 Madrid, Spain 
2) Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, 
Falmer, Brighton, UK  
 
§ These authors made equal contributions 







Cellular stability, assembly and activation of a growing list of macromolecular 
complexes require the action of HSP90 working in concert with the R2TP/Prefoldin-
like (R2TP/PFDL) co-chaperone. RNA polymerase II, snoRNPs and complexes of PI3-
kinase-like kinases, a family that includes the ATM, ATR, DNA-PKcs, TRAPP, SMG1 
and mTOR proteins, are among the clients of the HSP90-R2TP system. Evidence links 
the R2TP/PFDL pathway with cancer, most likely because of the essential role in 
pathways commonly deregulated in cancer. R2TP forms the core of the co-cochaperone 
and orchestrates the recruitment of HSP90 and clients, whereas prefoldin and additional 
prefoldin-like proteins, including URI, associate with R2TP, but their function is still 
unclear. The mechanism by which R2TP/PFLD facilitates assembly and activation of 
such a variety of macromolecular complexes is poorly understood. Recent efforts in the 
structural characterization of R2TP have started to provide some mechanistic insights. 
We summarize recent structural findings, particularly how cryo-electron microscopy 
(cryo-EM) is contributing to our understanding of the architecture of the R2TP core 
complex. Structural differences discovered between yeast and human R2TP reveal 
unanticipated complexities of the metazoan R2TP complex, and opens new and 
interesting questions about how R2TP/PFLD works. 
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1. The R2TP/Prefoldin-like (R2TP/PFDL) complex 
The HSP90 molecular chaperone assists for the assembly, cellular stability and 
activation of an eclectic set of macromolecular complexes. Despite much research on 
the structure and molecular processes involved, a profound mechanistic understanding 
of how HSP90 accomplishes its functions is still lacking. HSP90 participates in such a 
large variety of processes in part thanks to the assistance of co-chaperones. Co-
chaperones regulate HSP90 ATPase activity and help recruit specific client proteins to 
the chaperone (1). 
The R2TP/Prefoldin-like (R2TP/PFLD) complex is the most complex HSP90 co-
chaperone yet described (2, 3). R2TP forms a core assembly made of 4 different 
proteins (see next section), and this is essential for the assembly and stability of several 
macromolecular complexes, among these, small nucleolar ribonucleoproteins 
(snoRNPs) (4), RNA polymerase II (Pol II) (3) and the phosphatidylinositol-3-kinase-
like kinases (PIKKs) (5-9). The list of large assemblies requiring the assistance of 
HSP90 and R2TP for activation and stability is growing, including recent additions such 
as U5 snoRNPs (10, 11) and MRE11 (6, 12). 
 
In the cell, R2TP associates with additional subunits (3, 10). The best characterized are 
a collection of prefoldin and prefoldin-like proteins forming the so called prefoldin 
(PFLD) complex, whose exact function is unclear. In addition, a variety of adaptor 
proteins and complexes seem to participate in the recruitment of some HSP90 clients to 
the R2TP complex. It has been proposed that the PFLD module could be one of the 
adaptors involved in the R2TP-mediated assembly of RNA polymerase (3). Also, 
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Wdr92/Monad associates to the RPAP3 subunit of R2TP, and recent evidence suggest 
that Wdr92/Monad could contribute, in association to R2TP, to the assembly of 
axonemal dynein (13). Most of the currently known complexes needing the action of 
R2TP/PFLD have been found deregulated in cancer. Thus, the growing evidence 
implicating components of the R2TP/PFLD complex with cancer is no surprise (14-20). 
 
2. Composition of R2TP/PFDL  
Human R2TP comprises several copies of the AAA+ ATPases RUVBL1 and RUVBL2 
(Rvb1p, Rvb2p in yeast), interacting with RNA polymerase II associated protein 3, 
RPAP3 (Tah1p in yeast), and a Pih1 domain-containing protein 1, PIH1D1 (Pih1p in 
yeast) (Fig. 1). RUVBL1 and RUVBL2 assemble hetero-hexameric rings as well as 
dodecameric double-ring complexes that interact with RPAP3/Tah1p and 
PIH1D1/Pih1p (2, 5, 10). 
RPAP3, a protein initially identified and named by its association with RNA Pol II 
using protein affinity purification coupled to mass spectrometry (21), was subsequently 
ascribed as a component of R2TP (3, 22). RPAP3 contains two tandem N-terminal TPR 
domains that bind the conserved MEEVD C-terminal tail peptide of HSP90 (5, 23, 24) 
(Figure 1). Yeast Tah1p is a much smaller protein, comprising only 1 TPR (5, 25), 
although it has been shown to be able to form homodimers (26), but the importance of 
this observation in the context of the R2TP complex remains unknown. 
PIH1D1 mediates recruitment of some potential clients and adaptors to R2TP through 
an N-terminal phosphopeptide-binding PIH domain recognizing a specific motif 
produced by casein kinase 2 (CK2) phosphorylation (5, 6, 9). The PIH N-terminal 
domain acts as a phospho-peptide binding module, whereas a CS-domain at the C-
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terminus interacts with Tah1p (5, 25, 26). In yeast, Pih1p acts as the scaffold for the 
interaction with Tah1p and the Rvb1p-Rvb2p heterohexameric ring (27-29).  
Intriguingly, R2TP-like complexes can be formed when RUVBL1 and RUVBL2 
interact with dynein assembly factors (DNAAFs) containing TPR and PIH domains, and 
which would carry some of the functions of RPAP3 and PIH1D1 (13, 30). These R2TP-
like complexes would participate in the regulation of dynein assembly, but evidence for 
their existence in vivo was up to now mostly indirect. Just recently, Maurizy et al. 
(2018) describe several R2TP-like complexes detected by a systematic interaction 
analysis of the RPAP3 protein (31). Interestingly, these authors also reveal the 
formation of several R2TP-like complexes made of PIH-like and RPAP3-like proteins. 
 
In mammals, R2TP associates with proteins of the PFDL module. This comprises 
prefoldin and additional prefoldin-like proteins, URI, PFDN2, PFDN6, PDRG1 and 
UXT, which associate with Pol II subunits (3, 11). The interaction of the Pol II subunit 
RPB5 with URI (Unconventional prefoldin RPB5 Interactor) has been interpreted as 
indication that the prefoldin module would assist Pol II assembly as part of a 
R2TP/PFLD complex (3, 32). How this happens is still poorly understood. 
 
3. RUVBL1-RUVBL2, a platform for protein recruitment 
X-ray crystallography and cryo-EM have revealed the structural organization of 
RUVBL1/Rvb1p and RUVBL2/Rvb2p, two ATPases that are closely related (33-38). 
The ATPase core is made of domains I (DI) and III (DIII), interacting in the form of 
hetero-hexameric rings with alternating subunits. Domain II (DII) is flexibly attached 
and protrudes from the ring, and includes an oligonucleotide-binding (OB) domain, 
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which has been shown to interact with several unrelated proteins in the context of 
distinct complexes. 
Al least in humans (35, 39), yeast (33) and Chaeetomiun thermophilim (34), a 
thermophilic fungus, DII domains from two hexamers interact together via their DII 
domains to assemble a dodecameric complex. The functional significance of hexamers 
versus dodecamers is extensively debated. Although the role of these different 
structures has not yet been resolved, recent structural insights suggest that hexamers are 
likely the most common functional form of RUVBL1-RUVBL2, which plays a major 
role as a platform that scaffolds interaction with other proteins. Interestingly, in all 
cases where structures have been reported at sufficient resolution to map their 
components, it is the DII-face of hexameric RUVBL-rings and the DII domains 
themselves that direct the interaction with other proteins, whether the complex is yeast 
R2TP (27, 28) (Fig. 2A-C), INO80 (40, 41) (Fig. 2D) or human R2TP (39) (Fig. 3). In 
this model, hexamers would be the “active” form of RUVBL1-RUVBL2 complex, 
capable of interaction with other proteins, whereas the dodecameric complexes could 
represent a form not competent for binding and relatively less active in its ATPase 
activity. In support of this, Tah1p-Pih1p stimulates the ATPase activity of the 
hexameric form of Rvb1p-Rvb2p complex (27, 28). However, our recent structure of 
the human R2TP complex revealed, for the first time to our knowledge, that the ATPase 
side of the RUVBL-ring can also scaffold protein-protein interactions by interaction 
through RPAP3 (39), whose implications are discussed below. 
 
4. Structural understanding of client and HSP90 recruitment 
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A combination of biochemical and structural studies has provided a structural 
understanding of the basic features defining how R2TP recruits HSP90 and some of its 
clients. In yeast, a TPR domain in Tah1p interacts with the conserved MEEVD tail at 
the C-terminus of Hsp90 (Fig. 2C) (5, 25, 26, 42, 43). Tah1p (12 kDa) is substituted by 
RPAP3 (75 kDa) in metazoa, containing two TPR domains that can bind HSP90 (5). 
An unstructured C-terminal extension in Tah1p binds to the C-terminal CS domain in 
Pih1p (5, 25). The Pih1p-Tah1p complex is recruited to a hexameric ring of Rvb1p-
Rvb2p, making multiple contacts with several DII domains of Rvb1p and Rvb2p 
subunits (Fig 2B-C) (27, 28). At the N-terminus of Pih1p and the equivalent metazoan 
PIH1D1, a phosphopeptide-binding PIH domain recognizes a CK2-phosphorylation 
motif present in some clients, such as Mre11p, or adaptors such as Tel2p that participate 
in the recruitment of PIKKs to R2TP (5, 6). 
 
Not much is known about how R2TP recruits Pol II and other clients that do not contain 
the consensus PIH-binding motif. It has been proposed that several adaptors might 
connect R2TP and specific clients (2, 10, 11). Some of these potential adaptors contain 
a PIH-binding motif that could serve this function, but in many other cases, how R2TP 
adaptors and clients are brought together remains unknown.  
 
5. Cryo-EM to the rescue. Visualizing the architecture of R2TP 
The 3D architecture and stoichiometry of the components in the assembled R2TP 
complex has remained elusive and poorly understood, in part due to the difficulties 
associated with the crystallization of such a large complex. In addition, we now know 
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that these complexes are quite flexible, and thus are challenging for structural 
characterization. 
Recently, advances in cryo-electron microscope (cryo-EM) have permitted the 
structural characterization of a number of large complexes that have resisted 
crystallization for many years, the PIKK family of kinases being a good example, where 
the structure of all human PIKKs, except SMG1, have been reported at sub-nanometer 
resolution with in the last few years (44). Following this trend, the first cryo-EM 
structures of R2TP complexes, from yeast, were published in 2017 (27, 28), providing 
some light on the structural organization and stoichiometry of this complex. 
 
The first surprise was that both Rivera-Calzada et al. (2017), and Tian et al. (2017) 
revealed a 3:3:1:1 stoichiometry for the Rvb1p:Rvb2p:Tah1p:Pih1p complex in yeast 
(27, 28). Hexamers of Rvb1p-Rvb2p utilize their DII domains as a platform to interact 
with a copy of the Tah1p-Pih1p complex (Fig. 2A-C). Consequently, Rvb1p-Rvb2p 
double rings (dodecamers) are incompatible with the assembly of yeast R2TP. Given 
that each Rvb1p-Rvb2p ring is made of 3 molecules of Rvb1p and 3 molecules of 
Rvb2p, an understandable speculation was that up to 3 Tah1p-Pih1p complexes could 
bind each Rvb1p-Rvb2p ring. This would imply that several client-Hsp90 complexes 
could be managed by each R2TP. On the contrary, both studies clearly defined that only 
one Tah1p-Pih1p complex is accommodated within the cage formed by the DII domains 
of each Rvb1p-Rvb2p hexamer. Such stoichiometry has important implications in how 
yeast R2TP organizes clients and Hsp90, with each R2TP complex bringing in 
proximity one Hsp90 and one client, and avoiding the organization of super complexes 
containing several Hsp90 and clients per Rvb1p-Rvb2p ring. 
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Interestingly, Tah1p-Pih1p binding to Rvb1p-Rvb2p induces conformational changes in 
the DII domains that stimulate ATP hydrolysis, but the relevance and consequences of 
this in R2TP function remains to be elucidated. Tian et al. (2017) suggested that 
ATP/ADP contributes to R2TP disassembly, based on the preference for Rvb1p-Rvb2p 
top views versus side views in the electron microscope when R2TP is incubated with 
ATP (27). Nonetheless, this electron microscopy evidence is weak since it is well 
documented that nucleotide binding to AAA+ proteins can alter the preference of views 
in negative stain electron microscopy, and top views cannot be ascribed to either 
Rvb1p-Rvb2p or R2TP (27). 
 
6. Human R2TP, a flexible structure evolved to cope with a diversity of clients 
Recent cryo-EM of human R2TP revealed five remarkable features setting apart the 
much more elaborate architecture of human R2TP from the yeast complex (Fig. 3) (39). 
(a) Whereas Pih1p scaffolds the interaction of all other R2TP components in yeast, this 
function is taken over by RPAP3 in human R2TP. RPAP3, the HSP90 binding TPR 
domain-containing component of R2TP, scaffolds the binding of RUVBL1-RUVBL2 
and PIH1D1. Although cryo-EM suggests that PIH1D1 interacts with RUVBL1-
RUVBL2 (39), as in yeast R2TP (27, 28), interaction experiments clearly showed that 
PIH1D1 does not bind RUVBL1-RUVBL2 when RPAP3 C-terminal domain is not 
present (see next paragraph) (39). 
(b) RPAP3 is a much larger protein than yeast Tah1p, and cryo-EM reveals that an 
alpha-helical C-terminal domain in RPAP3 engages at the ATPase face of the RUVBL 
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ring (Fig. 2A-C), an interaction that is essential in holding the R2TP complex together. 
Interaction with the ATPase domains, rather than the DII face of the RUVBL ring, 
opens the possibility that other proteins could use a similar face/strategy to anchor to the 
RUVBL ring without the intervention of the DII domains. In this context, an NMR 
structure of the RPAP3 C-terminal domain has been also recently reported (Fig. 3D) 
(31), and the authors showed that two RPAP3-like proteins, CCDC103 and SPAG1, 
containing this domain, engage in the organization of R2TP-like complexes. 
(c) RPAP3 spans both faces of the RUVBL ring (Fig. 3A), with the N-terminal TPR-
containing regions in RPAP3, which are involved in HSP90 recruitment, locating to the 
DII face of the RUVBL ring where the PIH domain client-recruitment component maps. 
This would allow easy access of HSP90 to its clients. 
(d) The N-terminal HSP90 binding regions in RPAP3 are flexible and it can be 
envisioned that such architecture would facilitate the access of HSP90 to a large variety 
of complex clients that are recruited to R2TP. Perhaps, one of the roles of RPAP3 C-
terminal domain is providing a tight anchor of RPAP3 to the RUVBL ring, freeing the 
N-terminal TPR-HSP90 containing region. However, it is noted that in the yeast R2TP 
complex flexibility appears to be limited to the residues linking the TPR-binding 
MEEVD motif to the C-terminal domain of HSP90 (Fig. 2C). In any case, the 
adaptability of the RUVBL1-RUVBL2 complex could be further enhanced by the 
recruitment of clients that are structurally diverse by a collection of adaptors and 
apparently different mechanisms.  
(e) Each RUVBL ring can accommodate up to 3 RPAP3 molecules. The stoichiometry 
in vivo is unknown, but, since the R2TP core interacts with an ample number of 
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adaptors and proteins to facilitate assembly and stability of different complexes, a likely 
scenario would be that the number of RPAP3 molecules bound to each RUVBL ring 
will depend on the context of those other interactions. The interaction with other 
proteins and adaptors might only happen with a single RPAP3, so that there is free 
available space for other essential proteins to interact with the RUVBL ring. 
Alternatively, there might be occasions when the presence of more than one RPAP3 per 
R2TP complex might have functional relevance. These complexes could bring several 
HSP90 and several clients in proximity. At least for the assembly of Pol II, the 
existence of several assembly intermediate complexes has been described, which 
consist of different protein-subunits that need to be brought together for Pol II 
assembly. 
Together, the recent findings on the structure of the yeast and human R2TP core have 
revealed an elaborate structure that promotes the proximity between client and HSP90, 
and that inherent flexibility and adaptability allows such complexes to cope with diverse 
clients especially in the metazoan system. RPAP3 may play a major role in this 
flexibility, by providing a key scaffold function for other components of RUVBL1-
RUVBL2 complex. This key role of RPAP3 is underpinned by its C-terminal domain, 
whose function is to provide an anchor to the RUVBL ring. 
 
6. Conclusions and future perspectives 
The last two years have provided a significant advance in our structural and mechanistic 
understanding of the R2TP complex thanks to a combined effort of many groups and 
technologies. Cryo-EM has made an important contribution in providing a first 
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structural view of the full R2TP complex. This year, cryo-EM has also revealed the 
structure of other RUVBL-containing complexes, which is starting to build a view of 
these ATPases as flexible scaffolds of a variety of protein-protein interactions. 
Many questions remain open, and among them, is how URI, the prefoldin complex and 
other adaptors such as the TTT complex, associate to the R2TP core, and what this 
interaction means in both structural and functionally terms. It can be anticipated that the 
conformation of R2TP might be altered by its association with prefoldin and/or other of 
the several adaptors complexes that have been described. It can be expected that cryo-
EM will be a key technology in resolving such structures of these larger R2TP 
assemblies. 
The cryo-EM structure of human R2TP, supported by the NMR structure of RPAP3 C-
terminal domain, unexpectedly revealed that the ATPase face of the RUVBL is also 
utilized for protein-protein interactions. This opens the possibility that other proteins 
could also engage in this region, and additionally, that other regions in RUVBL could 
also function in protein binding. 
The R2TP/PFDL-HSP90 complex contains several ATP binding sites, which are 
required for assistance in client assembly, activation and stability. Exactly, how and 
why this works, in mechanistic terms, is completely unknown. Available evidence in 
yeast suggest that the interaction of Pih1p and Tah1p with Rvb1p/Rvb2p stimulates 
their ATPase activity (28), while inhibiting the ATPase activity of HSP90 (45), but a 
clear understanding of what this implies in mechanistic terms, is missing. The scenario 
is even less clear in the case of human R2TP, and this is an area that will need to be 
investigated in order understand how R2TP/PFDL functions. 
 13 
In summary, the last few years have significantly increased our structural and 
mechanistic understanding of how the R2TP/PFDL complex works. Despite these 
advances, the ultimate question of how R2TP/PFDL works together with HSP90 to 
assemble, stabilize and activate a variety of client complexes remains essentially 
unsolved. Further research from multiple perspectives and a collection of methods, 
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Figure 1. Components of the R2TP complex. 
(A) Components of the yeast R2TP, where Pih1p plays a central scaffolding role. 
Domains are indicated using different colors, and blue arrows are used to indicate 
interactions between the proteins in R2TP. Numbers represent amino acid residues. DII 
domain inserts within the DI domain, and the denomination of “insertion” domain is 
sometimes used for this domain. For simplicity, we DI and DIII domains are not 
labeled. 
(B) Components of the human R2TP, where RPAP3 scaffolds the interaction with 
PIH1D1 and RUVBL1-RUVBL2. HSP90 and PIH1D1 interacting regions in RPAP3 
are indicated with blue arrows. Domains are indicated using different colors, and blue 
arrows highlight interactions of RPAP3 with PIH1D1 and RUVBL2. Numbers represent 
amino acid residues. DII domain inserts within the DI domain, and DI and DIII domains 
are not indicated. 
 
 
Figure 2. Cryo-EM of yeast R2TP. 
(A) Representative 2D average of yeast R2TP obtained using negative stain electron 
microscopy (28), where domains and regions have been labeled. 
(B) Top view of the cryo-EM structure of yeast R2TP (28). Due to the limited 
resolution of the Pih1p-Tah1p components in the complex, a possible arrangement was 
proposed by fitting available crystal structures of Pih1p and Tah1p domains into the 
low-resolution density of the cryo-EM map. Tah1p is colored in yellow, and Pih1p in 
red. Rvb1p-Rvb2p is colored in blue, with the DII domains in darker blue color. 
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(C) Side view of the same complex shown in “b”. 
(D) Structure of the INO80 core complex from the fungus Chaetomium thermophilum, 
in complex with the nucleosome (40). In the complex, the DII domains of the Rvb1-
Rvb2 hetero-hexamer scaffold other subunits in the complex. 
 
Figure 3. Cryo-EM of human R2TP. 
(A) Representative 2D average of human R2TP (39), where domains and regions have 
been labeled. 
(B) Top view of the cryo-EM structure of RUVBL1-RUVBL2 bound to the C-terminal 
domain of RPAP3, obtained from the cryo-EM images of R2TP, but focusing 
refinement in the non-flexible regions (39). One copy of RPAP3 C-terminal domain is 
bound to each of the RUVBL2 subunits in the RUVBL1-RUVBL2 ring. Color codes: 
RUVBL1 (orange); RUVBL2 (blue); RPAP3 (yellow). 
(C) Side view of the same complex shown in “b”. The RPAP3 C-terminal domain binds 
to the ATPase side of the RUVBL ring. 
(D) Comparison of the model for the complex between RUVBL1-RUVBL2 and the C-
terminal domain of RPAP3 obtained by cryo-EM (39), and the NMR structure of the 
RPAP3 domain (31). 
 
Figure 4. Model of the structural architecture of yeast and human R2TP and the 
functional implications. 
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